Not logged in Share Save
Share Save
NCCN Guidelines® Insights: Multiple Myeloma, Version 1.2025 Kumar, Shaji K.; Callander, Natalie S.; Adekola, Kehinde; Anderson Jr, Larry D.; Baljevic, Muhamed; Baz, Rachid; Campagnaro, Erica; Costello, Caitlin; D'Angelo, Christopher; Derman, Benjamin; Devarakonda, Srinivas; Elsedawy, Noura; Godara, Amandeep; Godby, Kelly; Hillengass, Jens; Holmberg, Leona; Htut, Myo; Huff, Carol Ann; Hultcrantz, Malin; Kang, Yubin; Larson, Sarah; Lee, Hans C.; Liedtke, Michaela; Martin, Thomas; Omel, James; Robinson, Timothy; Rosenberg, Aaron; Schroeder, Mark A.; Sherbenou, Daniel; Suvannasankha, Attaya; Valent, Jason; Varshavsky-Yanovsky, Asya Nina; Vogl, Dan; Kovach, Emily; Kumar, Rashmi Share Save
Share Save
Share Save
Share Save
Cancer Surveillance in Solid Organ Transplant Recipients With a Pretransplant History of Malignancy: Multidisciplinary Collaborative Expert Opinion Watt, Kymberly D.; Rolak, Stacey; Foley, David P.; Plichta, Jennifer K.; Pruthi, Sandhya; Farr, Deborah; Zwald, Fiona O.; Carvajal, Richard D.; Dudek, Arkadiusz Z.; Sanger, Cristina B.; Rocco, Ricciardi; Chang, George J.; Dizon, Don S.; Langstraat, Carrie L.; Teoh, Deanna; Agarwal, Piyush K.; Al-Qaoud, Talal; Eggener, Scott; Kennedy, Cassie C.; D'Cunha, Jonathan; Mohindra, Nisha A.; Stewart, Shelby; Habermann, Thomas H.; Schuster, Stephen; Lunning, Matthew; Shah, Nirav N.; Gertz, Morie A.; Mehta, Jayesh; Suvannasankha, Attaya; Verna, Elizabeth; Farr, Maryjane; Blosser, Christopher D.; Hammel, Laura; Al-Adra, David P. Share Save
1q amplification and PHF19 expressing high-risk cells are associated with relapsed/refractory multiple myeloma Johnson, Travis S.; Sudha, Parvathi; Liu, Enze; Becker, Nathan; Robertson, Sylvia; Blaney, Patrick; Morgan, Gareth; Chopra, Vivek S.; Dos Santos, Cedric; Nixon, Michael; Huang, Kun; Suvannasankha, Attaya; Zaid, Mohammad Abu; Abonour, Rafat; Walker, Brian A. Share Save
Safety and efficacy of belantamab mafodotin with pembrolizumab in patients with relapsed or refractory multiple myeloma Suvannasankha, Attaya; Bahlis, Nizar; Trudel, Suzanne; Weisel, Katja; Koenecke, Christian; Oriol, Albert; Voorhees, Peter M.; Alonso, Aranzazu A.; Callander, Natalie S.; Mateos, Maria-Victoria; Reddy, Nishitha; Hakim, Shawn; Lamacchia, John; Patel, Nashita; Williams, Danae; Jewell, Roxanne. C.; Zhou, Xiangdong; Gupta, Ira; Opalinska, Joanna; Nooka, Ajay K. Share Save
Linvoseltamab, a B-cell maturation antigen-targeted T-cell-engaging bispecific antibody, induces deep and durable responses in patients with relapsed or refractory multiple myeloma including difficult-to-treat subgroups Jagannath, Sundar; Richter, Joshua; Dhodapkar, Madhav V.; Hoffman, James E.; Lee, Hans C.; Suvannasankha, Attaya; Shah, Mansi R.; Lentzsch, Suzanne; Zonder, Jeffrey A.; Baz, Rachid; Maly, Joseph J.; Namburi, Swathi; Wu, Ka Lung; Pianko, Matthew; Silbermann, Rebecca; Min, Chang-Ki; Vekemans, Marie-Christiane; Munder, Markus; Byun, Ja Min; Lopez, Joaquin Martinez; DeVeaux, Michelle; Chokshi, Dhruti; Boyapati, Anita; Hazra, Anasuya; Lorenc, Karen Rodriguez; Kroog, Glenn S.; Houvras, Yariv; Bumma, Naresh Share Save
Waldenstro m Macroglobulinemia/ Lymphoplasmacytic Lymphoma, Version 2.2024 Kumar, Shaji K.; Callander, Natalie S.; Adekola, Kehinde; Anderson, Larry D.; Baljevic, Muhamed; Campagnaro, Erica; Baz, Rachid; Castillo, Jorge J.; Costello, Caitlin; 'Angelo, Christopher; Derman, Benjamin; Devarakonda, Srinivas; Elsedawy, Noura; Garfall, Alfred; Godby, Kelly; Hillengass, Jens; Holmberg, Leona; Htut, Myo; Huff, Carol Ann; Hultcrantz, Malin; Kang, Yubin; Larson, Sarah; Lee, Hans; Liedtke, Michaela; Martin, Thomas; Omel, James; Robinson, Timothy; Rosenberg, Aaron; Sborov, Douglas; Schroeder, Mark A.; Sherbenou, Daniel; Suvannasankha, Attaya; Valent, Jason; Varshavsky-Yanovsky, Asya Nina; Snedeker, Jenna; Kumar, Rashmi Share Save
Multiple Myeloma, Version 2.2024 Kumar, Shaji K.; Callander, Natalie S.; Adekola, Kehinde; Anderson Jr, Larry D.; Baljevic, Muhamed; Baz, Rachid; Campagnaro, Erica; Castillo, Jorge J.; Costello, Caitlin; D'Angelo, Christopher; Devarakonda, Srinivas; Elsedawy, Noura; Garfall, Alfred; Godby, Kelly; Hillengass, Jens; Holmberg, Leona; Htut, Myo; Huff, Carol Ann; Hultcrantz, Malin; Kang, Yubin; Larson, Sarah; Lee, Hans C.; Liedtke, Michaela; Martin, Thomas; Omel, James; Robinson, Timothy; Rosenberg, Aaron; Sborov, Douglas; Schroeder, Mark A.; Sherbenou, Daniel; Suvannasankha, Attaya; Valent, Jason; Varshavsky-Yanovsky, Asya Nina; Kumar, Rashmi; Snedeker, Jenna Share Save
Share Save
DREAMM-2: Indirect Comparisons of Belantamab Mafodotin vs. Selinexor plus Dexamethasone and Standard of Care Treatments in Relapsed/Refractory Multiple Myeloma Prawitz, Thibaud; Popat, Rakesh; Suvannasankha, Attaya; Sarri, Grammati; Hughes, Rachel; Wang, Feng; Hogea, Cosmina; Ferrante, Shannon Allen; Gorsh, Boris; Willson, Jenny; Kapetanakis, Venediktos Share Save
Longer term outcomes with single-agent belantamab mafodotin in patients with relapsed or refractory multiple myeloma: 13-month follow-up from the pivotal DREAMM-2 study Lonial, Sagar; Lee, Hans C.; Badros, Ashraf; Trudel, Suzanne; Nooka, Ajay K.; Chari, Ajai; Abdallah, Al-Ola; Callander, Natalie; Sborov, Douglas; Suvannasankha, Attaya; Weisel, Katja; Voorhees, Peter M.; Womersley, Lynsey; Baron, January; Piontek, Trisha; Lewis, Eric; Opalinska, Joanna; Gupta, Ira; Cohen, Adam D. Share Save
Matching-adjusted indirect comparisons (MAIC) of safety between single-agent belantamab mafodotin versus selinexor plus dexamethasone in relapsed/refractory multiple myeloma (RRMM) Suvannasankha, A.; Prawitz, T.; Kapetanakis, V.; Sarri, G.; Hughes, R.; Wang, F.; Hogea, C.; Ferrante, S. Allen; Gutierrez, B.; Gorsh, B.; Willson, J.; Popat, R. Share Save
Share Save
Share Save
Cell Adhesion Molecule CD166 Drives Malignant Progression and Osteolytic Disease in Multiple Myeloma Xu, Linlin; Mohammad, Khalid S.; Wu, Hao; Crean, Colin; Poteat, Bradley; Cheng, Yinghua; Cardoso, Angelo A.; Machal, Christophe; Hanenberg, Helmut; Abonour, Rafat; Kacena, Melissa A.; Chirgwin, John; Suvannasankha, Attaya; Srour, Edward F. Share Save
Share Save